Tremfya I.v. 200 mg (Guselkumab SOLUTION) 200 MG

Tremfya I.V. 200 mg is a solution for intravenous use, containing guselkumab. This medication is designed to target specific immune responses, often used in managing chronic conditions. Learn more about its uses and effects.

Strength

200 MG

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tremfya I.V. 200 mg is primarily used for managing conditions related to immune system dysfunction. It is often prescribed for chronic inflammatory diseases. Patients may wonder, 'What is Tremfya I.V. used for?' Typically, it helps control symptoms and improve quality of life for those with long-term immune-related disorders.

Side Effects

Common effects of Tremfya I.V. 200 mg may include temporary discomfort at the injection site or mild systemic reactions. Some users report feeling fatigued or experiencing mild flu-like symptoms. These effects are generally short-lived and vary among individuals.

Precautions & Warnings

Tremfya I.V. 200 mg should be handled with care, following the healthcare provider's instructions. It is important to store the solution properly and use it as directed. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Tremfya I.V. 200 mg may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence its effects.

Frequently Asked Questions

Tremfya I.V. 200 mg is used to manage chronic inflammatory conditions by targeting specific immune responses.

Tremfya I.V. 200 mg is administered intravenously by a healthcare professional.

Common side effects may include temporary discomfort at the injection site, fatigue, and mild flu-like symptoms.

It is important to consult a healthcare provider before combining Tremfya I.V. with other medications to avoid potential interactions.

Tremfya I.V. should be stored according to the instructions provided by the healthcare provider or on the packaging.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.